De Nora and Aclarity sign agreement to deploy PFAS destroying technology
The MOU will involve product collaboration from both companies with a goal of propelling PFAS destruction in groundwater globally
The MOU will involve product collaboration from both companies with a goal of propelling PFAS destruction in groundwater globally
This partnership stemmed from a successful customer-supplier relationship spanning several years.
The patent also covers the efficacy of the herbal composition in the management of metabolic syndrome disorders
The investment will enable the company to enter European markets as well as enhance margins in current markets
Implants from the U.S. startup Allay Therapeutics are designed to relieve pain after knee surgery for up to three weeks
EC grants conditional marketing authorization based on the EFFISAYIL trial
The Institute will focus on increasing preparedness and laboratory capabilities for identification of novel and unknown zoonotic agents
This one-of-a-kind ophthalmic subspecialty division is focused on the treatment of the eye condition glaucoma
Patients receiving Polivy plus R-CHP for DLBCL reported similar health-related quality of life outcomes
Diclofenac Sodium Topical Solution, 2% w/w (RLD PENNSAID) had estimated annual sales of US $509 million in the US (IQVIA MAT October 2022)
Subscribe To Our Newsletter & Stay Updated